Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Identification of novel biomarkers to monitor β-cell function and enable early detection of type 2 diabetes risk.

Belongie KJ, Ferrannini E, Johnson K, Andrade-Gordon P, Hansen MK, Petrie JR.

PLoS One. 2017 Aug 28;12(8):e0182932. doi: 10.1371/journal.pone.0182932. eCollection 2017.

2.

Metabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and Hepatokines.

Oh KJ, Lee DS, Kim WK, Han BS, Lee SC, Bae KH.

Int J Mol Sci. 2016 Dec 22;18(1). pii: E8. doi: 10.3390/ijms18010008. Review.

3.

A change in objective sleep duration is associated with a change in the serum adiponectin level of women with overweight or obesity undergoing weight loss intervention.

Sawamoto R, Nozaki T, Furukawa T, Tanahashi T, Morita C, Hata T, Nakashima M, Komaki G, Sudo N.

Obes Sci Pract. 2016 Jun;2(2):180-188. Epub 2016 Mar 14.

4.

Adiponectin, Insulin Sensitivity, β-Cell Function, and Racial/Ethnic Disparity in Treatment Failure Rates in TODAY.

Arslanian S, El Ghormli L, Bacha F, Caprio S, Goland R, Haymond MW, Levitsky L, Nadeau KJ, White NH, Willi SM; TODAY Study Group.

Diabetes Care. 2017 Jan;40(1):85-93. doi: 10.2337/dc16-0455. Epub 2016 Nov 1.

PMID:
27803118
5.

Ethnic and Sex Differences in Adiponectin: From Childhood to Adulthood.

Ohman-Hanson RA, Cree-Green M, Kelsey MM, Bessesen DH, Sharp TA, Pyle L, Pereira RI, Nadeau KJ.

J Clin Endocrinol Metab. 2016 Dec;101(12):4808-4815. Epub 2016 Sep 7.

PMID:
27603898
6.

Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications.

Brannick B, Wynn A, Dagogo-Jack S.

Exp Biol Med (Maywood). 2016 Jun;241(12):1323-31. doi: 10.1177/1535370216654227. Review.

7.

Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program.

Goldberg RB, Temprosa M, Mele L, Orchard T, Mather K, Bray G, Horton E, Kitabchi A, Krakoff J, Marcovina S, Perreault L, White N; Diabetes Prevention Program Research Group.

Metabolism. 2016 May;65(5):764-75. doi: 10.1016/j.metabol.2015.11.011. Epub 2015 Dec 2.

8.

Adiponectin levels predict prediabetes risk: the Pathobiology of Prediabetes in A Biracial Cohort (POP-ABC) study.

Jiang Y, Owei I, Wan J, Ebenibo S, Dagogo-Jack S.

BMJ Open Diabetes Res Care. 2016 Mar 17;4(1):e000194. doi: 10.1136/bmjdrc-2016-000194. eCollection 2016.

9.

Associations of Adiponectin with Adiposity, Insulin Sensitivity, and Diet in Young, Healthy, Mexican Americans and Non-Latino White Adults.

Pereira RI, Low Wang CC, Wolfe P, Havranek EP, Long CS, Bessesen DH.

Int J Environ Res Public Health. 2015 Dec 22;13(1):ijerph13010054. doi: 10.3390/ijerph13010054.

10.

Do circulating blood cell types correlate with modifiable risk factors and outcomes in patients with acute coronary syndrome (ACS)?

Sharma KH, Shah KH, Patel I, Patel AK, Chaudhari S.

Indian Heart J. 2015 Sep-Oct;67(5):444-51. doi: 10.1016/j.ihj.2015.06.005. Epub 2015 Aug 6.

11.

Treatment-Induced Changes in Plasma Adiponectin Do Not Reduce Urinary Albumin Excretion in the Diabetes Prevention Program Cohort.

Mather KJ, Pan Q, Knowler WC, Funahashi T, Bray GA, Arakaki R, Falkner B, Sharma K, Goldstein BJ; DPP Research Group.

PLoS One. 2015 Aug 27;10(8):e0136853. doi: 10.1371/journal.pone.0136853. eCollection 2015.

12.

Steroid Sex Hormones, Sex Hormone-Binding Globulin, and Diabetes Incidence in the Diabetes Prevention Program.

Mather KJ, Kim C, Christophi CA, Aroda VR, Knowler WC, Edelstein SE, Florez JC, Labrie F, Kahn SE, Goldberg RB, Barrett-Connor E; Diabetes Prevention Program.

J Clin Endocrinol Metab. 2015 Oct;100(10):3778-86. doi: 10.1210/jc.2015-2328. Epub 2015 Jul 22. Erratum in: J Clin Endocrinol Metab. 2015 Dec;100(12):4686.

13.

Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns.

Papaetis GS, Papakyriakou P, Panagiotou TN.

Arch Med Sci. 2015 Jun 19;11(3):463-82. doi: 10.5114/aoms.2015.52350.

14.

Total and High Molecular Weight Adiponectin Levels and Prediction of Cardiovascular Risk in Diabetic Patients.

Horáková D, Azeem K, Benešová R, Pastucha D, Horák V, Dumbrovská L, Martínek A, Novotný D, Švagera Z, Hobzová M, Galuszková D, Janout V, Doněvská S, Vrbková J, Kollárová H.

Int J Endocrinol. 2015;2015:545068. doi: 10.1155/2015/545068. Epub 2015 May 5.

15.

Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention.

Hostalek U, Gwilt M, Hildemann S.

Drugs. 2015 Jul;75(10):1071-94. doi: 10.1007/s40265-015-0416-8. Review.

16.

Adiponectin, C-reactive protein, fibrinogen and tissue plasminogen activator antigen levels among glucose-intolerant women with and without histories of gestational diabetes.

Kim C, Christophi CA, Goldberg RB, Perreault L, Dabelea D, Marcovina SM, Pi-Sunyer X, Barrett-Connor E.

Diabet Med. 2016 Jan;33(1):32-8. doi: 10.1111/dme.12799. Epub 2015 May 29.

17.

A low-fat high-carbohydrate diet reduces plasma total adiponectin concentrations compared to a moderate-fat diet with no impact on biomarkers of systemic inflammation in a randomized controlled feeding study.

Song X, Kestin M, Schwarz Y, Yang P, Hu X, Lampe JW, Kratz M.

Eur J Nutr. 2016 Feb;55(1):237-46. doi: 10.1007/s00394-015-0841-1. Epub 2015 Feb 4.

18.

Effect of therapeutic dose of vitamin d on serum adiponectin and glycemia in vitamin d-insufficient or deficient type 2 diabetic patients.

Baziar N, Jafarian K, Shadman Z, Qorbani M, Khoshniat Nikoo M, Abd Mishani M.

Iran Red Crescent Med J. 2014 Sep 5;16(9):e21458. doi: 10.5812/ircmj.21458. eCollection 2014 Sep.

19.

Association of adipokines, leptin/adiponectin ratio and C-reactive protein with obesity and type 2 diabetes mellitus.

Al-Hamodi Z, Al-Habori M, Al-Meeri A, Saif-Ali R.

Diabetol Metab Syndr. 2014 Sep 16;6(1):99. doi: 10.1186/1758-5996-6-99. eCollection 2014.

20.

Younger age, higher body mass index and lower adiponectin concentration predict higher serum thromboxane B2 level in aspirin-treated patients with type 2 diabetes: an observational study.

Kaplon-Cieslicka A, Postula M, Rosiak M, Peller M, Kondracka A, Serafin A, Trzepla E, Opolski G, Filipiak KJ.

Cardiovasc Diabetol. 2014 Aug 15;13:112. doi: 10.1186/s12933-014-0112-0.

Supplemental Content

Support Center